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the primary and association audiovisual areas. Most lo-
cal maxima remained signifi cant after correcting for 
brain atrophy.  Conclusion: PET activity measured during 
audiovisual stimulation was more sensitive to functional 
alterations in  glucose metabolism in AD patients com-
pared to the resting PET. The association between glu-
cose metabolism and MMSE score was not dependent 
on brain atrophy. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 Alzheimer’s disease (AD) leads to regional neuronal 
and synaptic dysfunction in the brain. A sensitive index 
of neuronal and synaptic dysfunction is the regional ce-
rebral metabolism rate for glucose (rCMRglc) measured 
with positron emission tomography (PET)  [1, 2] . In the 
early stages of AD, hypometabolism has been found with-
in the temporal and parietal lobes  [3–7] . At the earliest 
clinical stages of the disease, compensatory mechanisms 
may lead to relatively stable resting metabolism levels  [8] 
but neuronal activity may not be suffi cient to respond 
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 Abstract 
 Background: Neuronal and synaptic function in Alzhei-
mer’s disease (AD) is measured in vivo by glucose me-
tabolism using positron emission tomography (PET). 
 Objective: We hypothesized that neuronal activation as 
measured by PET is a more sensitive index of neuronal 
dysfunction than activity during rest. We investigated if 
the correlations between dementia severity as measured 
with the Mini Mental State Examination (MMSE) and glu-
cose metabolism are an artifact of brain atrophy.  Meth-
od: Glucose metabolism was measured using [ 18 F]fl uo-
rodeoxyglucose PET during rest and activation due to 
audiovisual stimulation in 13 mild to moderate AD pa-
tients (MMSE score  6 17). PET data were corrected for 
brain atrophy.  Results: In the rest condition, glucose me-
tabolism was correlated with the MMSE score primarily 
within the posterior cingulate and parietal lobes. For the 
activation condition, additional correlations were within 
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fully to functional stimulation  [9–11] . In a group of pa-
tients with mild to severe AD, it was shown that rCMRglc 
was more sensitive to neuronal and synaptic dysfunc-
tion during audiovisual stimulation compared to resting 
rCMRglc  [12] . Thus, PET during stimulation could be a 
more sensitive index of neuronal and synaptic dysfunc-
tion compared to resting state PET  [13] . 
 Because of the low spatial resolution of the PET scan-
ner relative to the thickness of the grey matter (GM) lay-
er, the activity measured by PET is an average of activ-
ity of the GM and nearby tissue such as white matter and 
cerebrospinal fl uid  [14, 15] . This leads to an underestima-
tion of the rCMRglc activity in the GM called partial 
volume effects (PVE). In addition, brain atrophy com-
promises the PET assessment of neuronal and synaptic 
dysfunction because brain atrophy artifi cially decreases 
the measured brain metabolism. In mild AD patients, 
brain atrophy was present in regions that showed de-
creased glucose metabolism  [16, 17] . The matching pat-
tern of glucose metabolism abnormalities and brain atro-
phy suggested that the pattern of metabolism abnormali-
ties in mild AD patients may have been due in part to 
brain atrophy. 
 The objective of this study was to investigate if activa-
tion PET shows greater sensitivity to neural and synaptic 
dysfunction than resting PET in a group of patients with 
mild to moderate AD. In addition, we investigated the 
effect of PVE on the correlation between regional cortical 
glucose metabolism and MMSE score. This is the fi rst 
study that applies PVE correction to the analysis of rest-
ing and activation metabolism measurements based on 
GM volume. 
 Materials and Methods 
 Subjects 
 We studied 13 patients (male = 9) with AD [mean age = 66.9 
years, standard deviation (SD) = 8.6]. The patients met the NINCDC-
ADRDA criteria  [18] for probable AD and had an average MMSE 
score of 23.4 (SD = 3.5, range 17–29). The clinical evaluation in-
cluded medical, neurological, psychiatric, and neuropsychological 
examinations, laboratory testing, EEG, ECG and structural magnet-
ic resonance imaging (MRI). The presence of ischemic lesions in the 
patient group was excluded on the basis of T 2 -weighted MR scans. 
The patients gave their consent to the study after detailed informa-
tion on the study had been given to them. The study was approved 
by the Ethics Committee of the Medical Faculty of the Ludwig-Ma-
ximilian University and the Radiation Protection Authority. 
 PET and Magnetic Resonance Acquisition 
 A high-resolution Siemens ECAT HR+ PET scanner (Siemens/
CTI, Knoxville, Tenn., USA) was used to measure regional glucose 
metabolism. A transmission scan was done at the same level as the 










Inferior parietal lobule 40 54 –46 34 0.61 0.56
40 34 –56 40 0.68 0.64
40 64 –40 42 0.62 0.20
40 44 –52 44 0.67 0.56
Occipital lobe
Fusiform gyrus 18 16 –100 –20 0.69 0.54
Left hemisphere
Parietal lobe
Inferior parietal lobule 40 –48 –42 24 0.60 0.39
7 –44 –66 50 0.57 0.53
Posterior cingulate 31 0 –38 38 0.67 0.58
Temporal lobe
Inferior temporal gyrus 20 –42 12 –22 0.56 0.28
Occipital lobe
Precuneus 7 –4 –64 68 0.55 0.73
Cerebellum –38 –92 –20 0.61 0.69
–4 –90 –22 0.70 0.55
Table 1. Local maxima of the positive 
 correlation coeffi cients between resting 
glucose metabolism and MMSE scores 
 before PVE correction and after PVE 
 correction
 Bokde  et al.
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 Each patient underwent one PET scan for the rest and one for 
the audiovisual stimulation condition, respectively, where [18F]2-
fl uoro-2-deoxyglucose was used as a tracer. For the resting condi-
tion, the patients remained on the scanner bed (eyes patched and 
ears plugged). The audiovisual stimulation consisted of an episode 
of the movie ‘Wizard of Oz’, which was commenced after tracer 
injection and continued until the end of the data acquisition. The 
order of the scans (rest vs. stimulation) was randomized across pa-
tients. The data from the second scan were corrected for the re-
sidual radioactivity from the fi rst injection. Each condition was 
45 min in length and two 10-min scan frames (static) for each con-
dition were obtained. 
 The structural MR images were obtained on a Siemens Vision 
1.5-tesla scanner (Erlangen, Germany), using MPRAGE images. 
The fi eld of view was 28 cm with a voxel size of 0.5468  ! 0.5468 
 ! 1.25 mm. The MRI scans were acquired within 2 months of the 
acquisition of the PET scan. 
 Data Analysis 
 The PVE analyses were performed on a Linux computer (Red 
Hat version 6.0, Red Hat Inc., Rayleigh, N.C., USA). The algorithm 
corrects for PVE due to low resolution of the PET scanner com-
pared to the size of the GM thickness. The method uses each sub-
ject’s MR image to correct for PVE  [19] . 
 Statistical Analysis 
 The glucose metabolism images and PVE-corrected glucose me-
tabolism images were spatially normalized to the Montreal Neuro-
logical Institute stereotactic space  [20, 21] and smoothed using a 
Gaussian fi lter with a full width at half-maximum of 12  ! 12  ! 
12 mm using SPM99 (Wellcome Department of Cognitive Neurol-
ogy, London, UK). The normalized images were proportionally 
scaled to a mean of 10.  
 The correlation between the glucose metabolism values and the 
MMSE score was calculated at each voxel using software written in 










Supramarginal gyrus 40 –54 –50 –32 0.64 0.57
Inferior parietal lobule 40 –48 –54 –46 0.57 0.63
Paracentral lobule 31 –2 –24 –46 0.53 0.46
Posterior cingulate 31 –2 –40 –40 0.60 0.63
Superior parietal lobule 7 –32 –58 –40 0.67 0.64
Occipital lobe
Precuneus 7 –4 –56 –32 0.60 0.54
Cuneus 30 –22 –72 –12 0.67 0.35




Inferior parietal lobule 40 –52 –42 –38 0.63 0.45
40 –48 –64 –44 0.57 0.53
7 –30 –52 –44 0.62 0.49
Precuneus 7 –2 –62 –68 0.74 0.54
Superior parietal lobule 7 –46 –64 –52 0.54 0.57
7 –26 –80 –56 0.73 0.53
7 –20 –64 –70 0.60 0.50
Temporal lobe
Middle temporal gyrus 38 –52 –34 –2 0.58 0.48
Superior temporal gyrus 22 –50 –54 –18 0.56 0.50
Occipital Lobe
Middle occipital lobule 18 –30 –94 – 6 0.58 0.48
Inferior occipital lobule 19 –38 –94 –18 0.70 0.59
Cuneus 18 –12 –76 –16 0.68 0.41
19 –2 –90 –34 0.65 0.34
Fusiform gyrus 19 –48 –80 –18 0.56 0.46
Gyrus lingualis 17 –2 –92 –20 0.64 0.61
Cerebellum –52 –68 –24 0.59 0.52
Table 2. Local maxima of the positive 
 correlation coeffi cients between resting 
glucose metabolism and MMSE scores 
 after PVE correction and before PVE 
 correction
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cance level was set at p  ! 0.05 with a minimum cluster size of 10 
continuous voxels. It was decided before analysis was performed 
that we would focus on the occipital, temporal and parietal lobes 
because the temporal and parietal lobes are the fi rst and most af-
fected areas by AD and the audiovisual stimulation would have the 
greatest effects on the audiovisual system within the occipital and 
parietal lobes. 
 Results 
 The regions where the relative glucose metabolism 
during rest was signifi cantly correlated with the MMSE 
score are detailed in  table 1 . Before PVE correction, the 
local maxima were found in the right fusiform gyrus, left 
inferior temporal gyrus, left posterior cingulate, in the 
right and left inferior parietal lobule and left cerebellum. 
After correcting for PVE, 9 out of 12 local maxima re-
mained signifi cant. 
 The locations of the local maxima of the correlation 
coeffi cient map between the relative resting glucose me-
tabolism and the MMSE score after PVE correction are 
detailed in  table 2 . There were more regions of the brain 
that correlated with the MMSE score after PVE correc-
tion than before PVE correction. In particular, addition-
al regions of signifi cant correlations were located bilater-
ally within the occipital and parietal lobes. Of the local 
maxima of correlations after PVE correction, 12/24 did 
not remain signifi cant when no PVE was applied. 
 For passive audiovisual stimulation, the distributions 
of signifi cant correlations are shown in  table 3 . The local 
maxima were located in the early and association audio-
visual areas and in the parietal lobes. Most of the local 
maxima (15/17) remained signifi cant after PVE correc-
tion.  
 The locations of the local maxima of the correlation 
coeffi cient map after PVE correction between the acti-
vation glucose metabolism and the MMSE scores are 
detailed in  table 4 . In the right hemisphere, there were 
additional local maxima located in the fusiform gyrus, 
inferior temporal gyrus, and precuneus. In contrast to 
the uncorrected data, there were no local maxima lo-
cated in the cingulate gyrus. In the left hemisphere, ad-
ditional local maxima were located in the fusiform gy-
rus, superior occipital gyrus, middle temporal gyrus, 
precuneus, cingulate gyrus, and superior parietal lobule. 
Of the local maxima signifi cantly correlated after PVE 










Superior parietal lobule 7 –12 –66 54 0.80 0.68
Inferior parietal lobule 40 –44 –52 42 0.75 0.65
40 –44 –50 56 0.76 0.65
Cingulate gyrus 31 –10 –46 40 0.57 0.57
Temporal lobe
Middle temporal gyrus 39 –54 –64 12 0.58 0.56
Superior temporal gyrus 22 –52 –8 –2 0.55 0.51
Occipital lobe
Precuneus 19 –30 –84 40 0.58 0.58
Left hemisphere
Parietal lobe
Supramarginal gyrus 40 –56 –42 36 0.60 0.70
Postcentral gyrus 1 –52 –20 60 0.58 0.58
Inferior parietal lobule 7 –40 –66 46 0.80 0.79
Temporal lobe
Superior temporal gyrus 22 –50 –54 16 0.74 0.76
Occipital lobe
Cuneus 18 –22 –100 12 0.64 0.66
19 –16 –88 40 0.79 0.82
19 –8 –94 24 0.68 0.68
Precuneus 7 –4 –48 38 0.58 0.55
Table 3. Local maxima of the positive 
 correlation coeffi cients between activation 
glucose metabolism and MMSE scores 
 before PVE correction and after PVE 
 correction
 Bokde  et al.
 
 Dement Geriatr Cogn Disord 2005;20:352–357 356
 Discussion  
 The fi ndings from our study suggest that activation 
PET scans are more sensitive to neuronal and synaptic 
dysfunction than resting state PET when examining pa-
tients with mild to moderate AD. In addition, the results 
show that the correlation between glucose metabolism 
and the MMSE score is not an artifact of PVE. 
 Without PVE correction, relative glucose metabolism 
during the resting state was correlated with the MMSE 
score in the inferior parietal lobe bilaterally. Additionally, 
relative glucose metabolism during passive stimulation 
correlated with the MMSE score bilaterally in the infe-
rior and superior parietal areas. The fi nding of correla-
tions in the superior parietal lobule for the activation con-
dition indicates that additional areas of neuronal and syn-
aptic dysfunction were detected when compared to the 
resting condition.  
 In addition, for the activation paradigm, we found sig-
nifi cant correlations in the primary and association au-
diovisual areas of the brain. These areas are typically 
spared by AD. This is consistent with the idea that a con-
Region Broadman 
area






Superior parietal lobule 7 –34 –60 –44 0.69 0.66
Precuneus 7 –10 –66 –46 0.80 0.68
Superior parietal lobule 7 –30 –66 –54 0.67 0.54
Temporal lobe
Superior temporal gyrus 39 –52 –58 – 8 0.57 0.53
Middle temporal gyrus 19 –40 –80 –20 0.63 0.51
21 –62 –20 –6 0.60 0.33
Inferior temporal gyrus 37 –50 –70 –2 0.59 0.47
Occipital lobe
Cuneus 30 –18 –68 –10 0.67 0.20
19 –22 –84 –36 0.63 0.46
19 –10 –84 –28 0.57 0.19
Fusiform gyrus 19 –46 –62 –16 0.58 0.48
Left hemisphere
Parietal lobe
Precuneus 19 –14 –86 –40 0.86 0.77
Postcentral gyrus 5 –2 –38 –72 0.73 0.45
19 –34 –82 –38 0.76 0.67
Cingulate gyrus 31 –6 –44 –46 0.56 0.51
Inferior parietal lobule 40 –54 –42 –34 0.72 0.60
40 –44 –64 –46 0.81 0.78
Superior parietal lobule 7 –16 –64 –64 0.80 0.66
Temporal lobe
Superior temporal lobe –52 –26 – 6 0.57 0.51
–48 –56 –18 0.77 0.71
Middle temporal gyrus 22 –52 –40 – 6 0.58 0.43
–46 –68 – 8 0.69 0.66
Occipital lobe
Cuneus 19 –14 –86 –40 0.86 0.77
19 –10 –84 –28 0.57 0.19
18 –6 –92 –22 0.74 0.62
Superior occipital gyrus 19 –32 –88 –24 0.71 0.57
Fusiform gyrus 19 –40 –76 –10 0.56 0.45
Precuneus 19 –34 –82 –38 0.75 0.67
31 –4 –56 –36 0.60 0.57
Cerebellum –44 –52 –20 0.59 0.52
Table 4. Local maxima of the positive 
 correlation coeffi cients between activation 
glucose metabolism and MMSE scores 
 after PVE correction and before PVE 
 correction
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dition that stimulates the brain would be more sensitive 
to neuronal and synaptic dysfunction than a resting con-
dition  [9, 11, 22] . 
 The results obtained show that the association between 
MMSE score and glucose metabolism was for most local 
maxima robust to PVE correction. In addition, PVE cor-
rection revealed additional correlations in additional 
brain areas. For the resting condition, these additional 
areas were located in early visual and audiovisual asso-
ciation areas. For the passive stimulation state, PVE cor-
rection led to an increase in the number of local maxima, 
but the regional distribution did not change compared to 
the noncorrected data. These fi ndings suggest that PVE 
correction enhances the sensitivity of PET to detect AD-
related functional failure. 
 In summary, activation PET was more sensitive to 
neuronal and synaptic dysfunction in a group of mild to 
moderate impaired AD patients compared to resting PET 
scans. The magnitude and distribution of the regional 
correlations were not an artifact of GM atrophy.  
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